Sarah K. Tate

1.7k total citations
8 papers, 805 citations indexed

About

Sarah K. Tate is a scholar working on Pediatrics, Perinatology and Child Health, Oncology and Psychiatry and Mental health. According to data from OpenAlex, Sarah K. Tate has authored 8 papers receiving a total of 805 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Pediatrics, Perinatology and Child Health, 4 papers in Oncology and 4 papers in Psychiatry and Mental health. Recurrent topics in Sarah K. Tate's work include Drug Transport and Resistance Mechanisms (4 papers), Epilepsy research and treatment (4 papers) and Pharmacological Effects and Toxicity Studies (4 papers). Sarah K. Tate is often cited by papers focused on Drug Transport and Resistance Mechanisms (4 papers), Epilepsy research and treatment (4 papers) and Pharmacological Effects and Toxicity Studies (4 papers). Sarah K. Tate collaborates with scholars based in United Kingdom, United States and Belgium. Sarah K. Tate's co-authors include Sanjay M. Sisodiya, David B. Goldstein, David B. Goldstein, Nicholas Wood, Arjune Sen, Chantal Depondt, Gianpiero L. Cavalleri, Josemir W. Sander, Maria Thom and Nicole Soranzo and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Genetics and Nature Reviews Genetics.

In The Last Decade

Sarah K. Tate

8 papers receiving 768 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Sarah K. Tate United Kingdom	7	324	298	251	214	186	8	805
A. Tran France	9	436 1.3×	371 1.2×	151 0.6×	98 0.5×	222 1.2×	15	801
Takateru Ishitsu Japan	17	425 1.3×	474 1.6×	170 0.7×	54 0.3×	273 1.5×	29	767
Pallav Bhatnagar United States	14	115 0.4×	135 0.5×	207 0.8×	212 1.0×	178 1.0×	28	1.2k
Britt I. Drögemöller Canada	20	55 0.2×	116 0.4×	369 1.5×	292 1.4×	216 1.2×	54	1.0k
Asra Tus Saleha Siddiqui United Kingdom	5	290 0.9×	366 1.2×	431 1.7×	68 0.3×	352 1.9×	7	958
Eugène Cox United States	12	93 0.3×	85 0.3×	154 0.6×	39 0.2×	182 1.0×	22	623
Takayuki Seo Japan	10	314 1.0×	357 1.2×	76 0.3×	34 0.2×	246 1.3×	15	532
Etienne Pigeolet Switzerland	12	333 1.0×	316 1.1×	56 0.2×	37 0.2×	102 0.5×	15	565
A. H. Schinkel Netherlands	6	56 0.2×	193 0.6×	123 0.5×	45 0.2×	339 1.8×	15	525
L. J. Sheffield Australia	11	46 0.1×	123 0.4×	267 1.1×	193 0.9×	45 0.2×	16	490

Countries citing papers authored by Sarah K. Tate

Since Specialization

Citations

This map shows the geographic impact of Sarah K. Tate's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sarah K. Tate with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sarah K. Tate more than expected).

Fields of papers citing papers by Sarah K. Tate

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sarah K. Tate. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sarah K. Tate. The network helps show where Sarah K. Tate may publish in the future.

Co-authorship network of co-authors of Sarah K. Tate

This figure shows the co-authorship network connecting the top 25 collaborators of Sarah K. Tate. A scholar is included among the top collaborators of Sarah K. Tate based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sarah K. Tate. Sarah K. Tate is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

1.

Tate, Sarah K., Peter Kinirons, Michael E. Weale, et al.. (2008). No major role of common SV2A variation for predisposition or levetiracetam response in epilepsy. Epilepsy Research. 83(1). 44–51. 30 indexed citations

2.

Tate, Sarah K. & Sanjay M. Sisodiya. (2007). Multidrug resistance in epilepsy: a pharmacogenomic update. Expert Opinion on Pharmacotherapy. 8(10). 1441–1449. 36 indexed citations

3.

Heinzen, Erin L., Woohyun Yoon, Sarah K. Tate, et al.. (2007). Nova2 Interacts with a Cis-Acting Polymorphism to Influence the Proportions of Drug-Responsive Splice Variants of SCN1A. The American Journal of Human Genetics. 80(5). 876–883. 86 indexed citations

4.

Tate, Sarah K., Rinki Singh, Chin‐Chuan Hung, et al.. (2006). A common polymorphism in the SCN1A gene associates with phenytoin serum levels at maintenance dose. Pharmacogenetics and Genomics. 16(10). 721–726. 75 indexed citations

5.

Tate, Sarah K., Chantal Depondt, Sanjay M. Sisodiya, et al.. (2005). Genetic predictors of the maximum doses patients receive during clinical use of the anti-epileptic drugs carbamazepine and phenytoin. Proceedings of the National Academy of Sciences. 102(15). 5507–5512. 238 indexed citations

6.

Tate, Sarah K. & David B. Goldstein. (2004). Will tomorrow's medicines work for everyone?. Nature Genetics. 36(S11). S34–S42. 115 indexed citations

7.

Goldstein, David, Sarah K. Tate, & Sanjay M. Sisodiya. (2004). Correction: Pharmacogenetics goes genomic. Nature Reviews Genetics. 5(1). 76–76. 2 indexed citations

8.

Goldstein, David B., Sarah K. Tate, & Sanjay M. Sisodiya. (2003). Pharmacogenetics goes genomic. Nature Reviews Genetics. 4(12). 937–947. 223 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact